Autobahn Labs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published: Dec 21, 2020 Autobahn Labs and UCSF will establish new ventures for drug discovery and development PALO ALTO, Calif. and SAN FRANCISCO, Dec. 21, 2020 /PRNewswire/ Autobahn Labs, a virtual incubator partnering with top academic and research institutions to catalyze early-stage drug discovery and development, today announced a strategic collaboration with the University of California San Francisco (UCSF). The organizations will partner to identify promising early science with significant therapeutic potential, forming jointly owned ventures to accelerate the translation of scientific ideas to novel therapeutics. UCSF combines world-class medicine, cutting-edge research, and a strong track record of innovation in drug discovery, said Thomas Novak, PhD, Chief Scientific Officer of Autobahn Labs. We re excited to partner their great science with Autobahn Labs resources and capabilities to spark the development of meaningful new therapies for patients.

United statesUniversity of california san franciscoSan franciscoBarry selickThomas novakWerner lanthalerMichelle kim danelyUniversity of californiaInnovation development generation efficiencyAutobahn labBiomedical researchCalifornia san franciscoChief scientific officerSinnovation venturesAutobahn labsSamsara biocapital